HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 43 filers reported holding HARPOON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -33.3% | 1,977 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -6.2% | 1,977 | 0.0% | 0.00% | – |
| Q3 2021 | $16,000 | -40.7% | 1,977 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | -12.9% | 1,977 | +34.3% | 0.00% | – |
| Q1 2021 | $31,000 | +40.9% | 1,472 | +10.8% | 0.00% | – |
| Q4 2020 | $22,000 | -4.3% | 1,329 | 0.0% | 0.00% | – |
| Q3 2020 | $23,000 | -20.7% | 1,329 | -23.7% | 0.00% | – |
| Q2 2020 | $29,000 | +123.1% | 1,741 | +57.0% | 0.00% | – |
| Q1 2020 | $13,000 | -38.1% | 1,109 | -15.7% | 0.00% | – |
| Q4 2019 | $21,000 | +31.2% | 1,316 | +9.7% | 0.00% | – |
| Q3 2019 | $16,000 | +100.0% | 1,200 | +76.5% | 0.00% | – |
| Q2 2019 | $8,000 | +33.3% | 680 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | – | 680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $75,105,000 | 22.35% |
| MPM BioImpact LLC | 3,898,422 | $64,714,000 | 17.21% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $48,495,000 | 13.92% |
| Avidity Partners Management LP | 1,206,351 | $20,025,000 | 1.28% |
| Consonance Capital Management LP | 844,162 | $14,013,000 | 0.84% |
| Orbimed Advisors | 1,835,704 | $30,473,000 | 0.43% |
| Artal Group S.A. | 900,000 | $14,940,000 | 0.42% |
| Cormorant Asset Management, LP | 645,257 | $10,711,000 | 0.41% |
| DAFNA Capital Management LLC | 85,119 | $1,413,000 | 0.41% |
| Soleus Capital Management, L.P. | 30,886 | $512,000 | 0.29% |